Literature DB >> 32437342

Surveillance to Track Progress Toward Polio Eradication - Worldwide, 2018-2019.

Jacquelyn S Lickness, Tracie Gardner, Ousmane M Diop, Smita Chavan, Jaume Jorba, Jamal Ahmed, Nicksy Gumede, Ticha Johnson, Obaid Butt, Humayun Asghar, Eugene Saxentoff, Varja Grabovac, Tigran Avagyan, Sudhir Joshi, Gloria Rey-Benito, Jane Iber, Elizabeth Henderson, Steven G F Wassilak, Abhijeet Anand.   

Abstract

Since the Global Polio Eradication Initiative (GPEI) was launched in 1988, the number of polio cases worldwide has declined approximately 99.99%; only two countries (Afghanistan and Pakistan) have never interrupted wild poliovirus (WPV) transmission (1). The primary means of detecting poliovirus circulation is through surveillance for acute flaccid paralysis (AFP) among children aged <15 years with testing of stool specimens for WPV and vaccine-derived polioviruses (VDPVs) (genetically reverted strains of the vaccine virus that regain neurovirulence) in World Health Organization (WHO)-accredited laboratories (2,3). In many locations, AFP surveillance is supplemented by environmental surveillance, the regular collection and testing of sewage to provide awareness of the extent and duration of poliovirus circulation (3). This report presents 2018-2019 poliovirus surveillance data, focusing on 40 priority countries* with WPV or VDPV outbreaks or at high risk for importation because of their proximity to a country with an outbreak. The number of priority countries rose from 31 in 2018 to 40 in 2019 because of a substantial increase in the number of VDPV outbreaks† (2,4). In areas with low poliovirus immunity, VDPVs can circulate in the community and cause outbreaks of paralysis; these are known as circulating vaccine derived polioviruses (cVDPVs) (4). In 2019, only 25 (63%) of the 40 designated priority countries met AFP surveillance indicators nationally; subnational surveillance performance varied widely and indicated focal weaknesses. High quality, sensitive surveillance is important to ensure timely detection and response to cVDPV and WPV transmission.

Entities:  

Mesh:

Year:  2020        PMID: 32437342     DOI: 10.15585/mmwr.mm6920a3

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  7 in total

1.  Progress Toward Polio Eradication - Worldwide, January 2018-March 2020.

Authors:  Anna N Chard; S Deblina Datta; Graham Tallis; Cara C Burns; Steven G F Wassilak; John F Vertefeuille; Michel Zaffran
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-06-26       Impact factor: 17.586

2.  Impact of sampling depth on pathogen detection in pit latrines.

Authors:  Drew Capone; Petros Chigwechokha; Francis L de Los Reyes; Rochelle H Holm; Benjamin B Risk; Elizabeth Tilley; Joe Brown
Journal:  PLoS Negl Trop Dis       Date:  2021-03-02

3.  Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in Africa.

Authors:  Laura V Cooper; Ananda S Bandyopadhyay; Nicksy Gumede; Ondrej Mach; Pascal Mkanda; Modjirom Ndoutabé; Samuel O Okiror; Alejandro Ramirez-Gonzalez; Kebba Touray; Sarah Wanyoike; Nicholas C Grassly; Isobel M Blake
Journal:  Lancet Infect Dis       Date:  2021-10-11       Impact factor: 25.071

4.  Relationship Between Helicobacter pylori IgG Seroprevalence and the Immune Response to Poliovirus Vaccine Among School-Age Children From a Population With Near-Universal Immunity Level.

Authors:  Layaly Badran Abu Zher; Merav Weil; Eias Kassem; Nael Elias; Myron M Levine; Khitam Muhsen
Journal:  Front Med (Lausanne)       Date:  2022-01-20

5.  Environmental Surveillance for Polioviruses in Haïti (2017-2019): The Dynamic Process for the Establishment and Monitoring of Sampling Sites.

Authors:  Mary M Alleman; Angela D Coulliette-Salmond; Pierre Wilnique; Hanen Belgasmi-Wright; Leanna Sayyad; Kimberly Wong; Edmund Gue; Robert Barrais; Gloria Rey-Benito; Cara C Burns; Everardo Vega
Journal:  Viruses       Date:  2021-03-18       Impact factor: 5.048

6.  Surveillance to Track Progress Toward Polio Eradication - Worldwide, 2019-2020.

Authors:  Jude N Tuma; Amanda L Wilkinson; Ousmane M Diop; Jaume Jorba; Tracie Gardner; Cynthia J Snider; Abhijeet Anand; Jamal Ahmed
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-05-07       Impact factor: 35.301

7.  Environmental Surveillance for Risk Assessment in the Context of a Phase 2 Clinical Trial of Type 2 Novel Oral Polio Vaccine in Panama.

Authors:  Magda Rojas-Bonilla; Angela Coulliette-Salmond; Hanen Belgasmi; Kimberly Wong; Leanna Sayyad; Everardo Vega; Fabian Grimoldi; M Steven Oberste; Ricardo Rüttimann
Journal:  Viruses       Date:  2021-07-13       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.